Integral Diagnostics Ltd (IDX) — Capital Reinvestment Ratio
Latest as of June 2025:
0.64x
Integral Diagnostics Ltd (IDX) has a Capital Reinvestment Ratio of 0.64x as of June 2025, meaning it reinvests 1% of its operating cash flow (AU$51.60 Million) in capital expenditures (AU$32.90 Million). See Integral Diagnostics Ltd (IDX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.64x
Capex / Operating Cash Flow
Operating Cash Flow
AU$51.60 Million
AUD
Capital Expenditures
AU$32.90 Million
AUD
Data as of
Jun 2025
Most recent filing
Integral Diagnostics Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks Integral Diagnostics Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Integral Diagnostics Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for Integral Diagnostics Ltd from 2014 to 2025. For live market cap and broader valuation context, see Integral Diagnostics Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.81x | AU$73.77 Million | AU$59.76 Million | ▲ +124.4% |
| 2024 | 0.36x | AU$66.16 Million | AU$23.88 Million | ▼ -41.4% |
| 2023 | 0.62x | AU$71.42 Million | AU$43.99 Million | ▼ -17.7% |
| 2022 | 0.75x | AU$37.10 Million | AU$27.77 Million | ▲ +156.9% |
| 2021 | 0.29x | AU$69.57 Million | AU$20.27 Million | ▼ -38.9% |
| 2020 | 0.48x | AU$54.25 Million | AU$25.88 Million | ▼ -13.3% |
| 2019 | 0.55x | AU$33.92 Million | AU$18.67 Million | ▲ +26.0% |
| 2018 | 0.44x | AU$26.52 Million | AU$11.58 Million | ▼ -14.8% |
| 2017 | 0.51x | AU$22.73 Million | AU$11.65 Million | ▼ -28.4% |
| 2016 | 0.72x | AU$24.05 Million | AU$17.22 Million | ▲ +527.0% |
| 2015 | 0.11x | AU$17.11 Million | AU$1.95 Million | ▼ -78.4% |
| 2014 | 0.53x | AU$3.70 Million | AU$1.95 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow